http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DO-P2005000062-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0a9e6421e9257148abad101e1ce6c162
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D451-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D237-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-32
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D317-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D451-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D237-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D405-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D409-14
filingDate 2005-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58788bc22a57c07ce0f946c9dab99c10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c66088514c7ab7c660dcb52eb8bf6090
publicationDate 2006-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber DO-P2005000062-A
titleOfInvention DERIVATIVES OF 1-AMINO-FTALAZINA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
abstract The invention relates to derivatives of 1-aminophthalazine, of general formula (I): wherein A, B = alkylene-Cl-4, optionally substituted; L = single bond or C1-2 alkylene, -CH = CH- optionally substituted, or -C = C-, or cycloprop-l, 2-diyl; R1 = optionally substituted aryl or heteroaryl; R2, R3 = H, C3-3 alkyl, C1-3 fluoroalkyl or R2 and R3 together form, with the carbon atom that carries them, a cycloprop-1, 1-diyl; R4 = H, C1-5 alkyl, fluroalkyl-C1-3, cycloalkyl-C3-6, cycloalkyl-C3-6-alkylene-C1-3, alkyl-C, 1-3-0-alkylene-Cl-3, HO-C1-3-alkylene, Cl-3-X-alkylene-Cl-3 alkyl wherein X = S, SO or S02; or R4, = RaRbN-alkylene-Cl-3, aryl, aryl-alkyleneCl-3, aryl-O, aryl-O-C1-3 alkylene; aryl-alkylene-Cl-3-Oalkylene-Cl-3, heteroaryl or heteroaryl-C1-3 alkylene; R5 = H, halogen, C1-5 alkyl, fluoroalkyl-Cl-3, alkoxy-Cl-5, fluoroalkoxy-C1-3, HO-C1-3 alkylene, -CN, C1-3-X alkyl where X = S, SO or S02; or R5 = RaRbN-, RaRbN-C1-3 alkylene, aryl, aryl-C1-3 alkylene, aryl-O- or heteroaryl; R6 = H, halogen, C1-5 alkyl, C1-3 fluoroalkyl, C1-5 alkoxy, C1-3 fluoroalkoxy, -CN, RaRbN-, RaRbN-C1-3 alkylene, aryl or heteroaryl; R7 = H, halogen, C1,5 alkyl, fluoroalkyl-C1-3, alkoxy-Cl-5, fluoroalkoxy-C1-3, HO-alkylene-Cl-3, -CN, alkyl C1-3-X- where X = S, SO or SO2; or RaRbN-, RaRbN-alkylene-C, 3, RaRbNC (0) -, C1-3-C alkyl (0) -, aryl, aryl-O- or heteroaryl; RB = H, halogen, C1-5 alkyl, C1-5 alkoxy, C1-3 fluoroalkoxy; in the base or salt state of addition of an acid, as well as in the state of hydrate or solvate. Procedure of preparation and application in therapy.
priorityDate 2004-04-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID29399
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420313639

Total number of triples: 53.